InfectRisk

COVID-19 in Poland

Current COVID-19 activity in Poland, based on ECDC ERVISS weekly data, set against the parallel flu and RSV trajectories.

This page tracks how much COVID-19 is circulating, not symptoms or diagnosis.

Influenza: Low

Low

The source currently reports no meaningful activity (as of 16 Aug 2026).

Data window: Week 33 · Aug 10 – Aug 16 · Source: ECDC (weekly) · Source on seasonal break, next data from week 40

Get one free alert when the wave turns in Poland

We write exactly once: the moment the level goes up. No account, no newsletter. We store your address and the country, nothing else. Every mail has a one click unsubscribe. Privacy

View the last 8 weeks

In week 33 of 2026, Influenza activity in Poland is classified as low.

The source reports no meaningful activity across these weeks; a week-over-week percentage would be pure noise here.

The last 8 reported weeks

WeekRelativeLevelvs prior week
Week 33Low
Week 32Low
Week 31Low
Week 30Low
Week 29Low
Week 28Low
Week 27Low
Week 26Low

Across these weeks the source reports no meaningful activity, the values sit at the floor of its scale.

Is flu going around right now?

Know when it affects you.

This page shows your country. The app shows you.

  • Exact numbers and incidence rates, not just low, moderate, high
  • Your personal risk by age and region
  • A push alert when the wave tips in your region
  • 35 countries and a home-screen widget
Download on the

Current activity

12-week trend · COVID-19 · Relative development · ECDC ERVISS weekly data
Week 22Week 25Week 28Week 30Week 33
  • InfluenzaLow
    Trend: stable · Week 33
  • COVID-19Low
    Trend: stable · Week 33
  • RSVLow
    Trend: stable · Week 33

What this means

In week 33 of 2026, activity of COVID-19 in Poland is low. The trend, derived from clinical surveillance, is stable. Activity has barely shifted over the past few weeks.

Data, context and methodology

The current picture for Poland is built on the European Respiratory Virus Surveillance Summary (ERVISS), published weekly by the European Centre for Disease Prevention and Control (ECDC). the National Institute of Public Health (NIZP PZH) via the SENTINEL system is the national public-health authority that feeds ERVISS with sentinel primary care and virology data.

ECDC ERVISS

ERVISS is ECDC's weekly pan-European surveillance summary for influenza, SARS-CoV-2 and RSV. National authorities, in Poland's case the National Institute of Public Health (NIZP PZH) via the SENTINEL system, submit harmonised indicators every week, which ECDC publishes in a standardised dataset on Thursdays. Using ERVISS rather than each country's native portal ensures cross-country comparability.

ILI / ARI consultation rates and positivity

the National Institute of Public Health (NIZP PZH) via the SENTINEL system operates a sentinel network of general practices that report weekly rates of patients consulting for influenza-like illness (ILI) or acute respiratory infection (ARI). A subset of patients is swabbed and tested by reference laboratories, producing pathogen-specific positivity rates for flu, SARS-CoV-2 and RSV.

Why this source

Combining consultation incidence with virological positivity yields a pathogen-specific weekly incidence signal (ILI × positivity / 100). This is the standard European methodology and provides a more robust view than either indicator alone: consultation rates capture illness burden, positivity confirms which pathogen is driving it.

Qualitative classification

The “low”, “moderate” and “high” categories follow seasonal reference values and epidemiological thresholds calibrated to match our classifications for other countries. The ILI × positivity / 100 product is scaled to comparable thresholds using a divisor of 3, which aligns European sentinel peaks with the consultation-equivalent scale used elsewhere. Data refreshes weekly when ECDC publishes the latest ERVISS update, typically on Thursdays.

Source and seasonal pattern by pathogen

Influenza
The classification is based on the ECDC ERVISS weekly reports, drawing on sentinel and virological data from the National Institute of Public Health NIH - National Research Institute (NIZP PZH). Seasonally, infection waves in Poland typically peak between January and March; activity is usually markedly lower during the summer months.
COVID-19
The classification is based on the ECDC ERVISS weekly reports, drawing on COVID-19 indicators from Poland's National Institute of Public Health NIH - National Research Institute (NIZP PZH). Seasonally, infection waves in Poland typically peak during winter, with occasional summer waves driven by new variants; activity is usually markedly lower in late spring between waves.
RSV
The classification is based on the ECDC ERVISS weekly reports, drawing on RSV indicators from Poland's National Institute of Public Health NIH - National Research Institute (NIZP PZH). Seasonally, infection waves in Poland typically peak between December and February; activity is usually markedly lower in spring and summer.

Frequently asked questions

How is COVID-19 tracked in Poland?

COVID-19 surveillance in Poland sits inside the broader respiratory-virus framework run by NIZP PZH. SARS-CoV-2 is reported alongside influenza and RSV via sentinel and non-sentinel networks, with results feeding into ECDC's ERVISS platform. Since mass testing wound down, the useful signals are laboratory positivity among tested respiratory samples, hospital admissions for severe acute respiratory infection, and, where available, variant sampling.

Does Poland still see distinct COVID-19 waves?

Yes, but the pattern is less tightly seasonal than influenza. Poland has seen recurring autumn and winter waves, often triggered by new Omicron sublineages that partially escape earlier immunity. Summer upticks occur as well. Because NIZP PZH reports COVID-19 within the combined respiratory panel, waves are now read as shifts in positivity and hospitalisation rather than through absolute case counts.

How does Poland's COVID-19 signal appear in ECDC data?

Poland contributes SARS-CoV-2 positivity and severity indicators to ECDC's ERVISS and country profiles. This allows a direct comparison of Polish trends with those of Germany, Czechia, Slovakia, and other neighbours. Because all countries use the same reporting template, relative intensity (low, moderate, high, very high) is meaningful across borders, even if absolute numbers are not fully comparable.

Is COVID-19 still considered dangerous in Poland?

For most people with vaccine- or infection-induced immunity, current variants behave like a moderate respiratory illness. Risk remains concentrated in older adults, immunocompromised patients, and people with chronic heart or lung disease. Polish public-health guidance continues to recommend seasonal booster doses for risk groups, aligned with ECDC and WHO Europe recommendations. Ongoing surveillance is what allows that risk to be managed without blanket restrictions.

How do I interpret qualitative COVID-19 activity levels?

NIZP PZH and ECDC use tiered activity classifications, baseline through very high, derived from historical positivity and severity ranges. These tiers describe how the current week compares with previous seasons, not how many people are infected in absolute terms. A shift from moderate to high signals meaningful additional pressure on primary care and hospitals, even when case-level data is incomplete.

More situation reports

ECDC ERVISSECDC DataUpdated: Aug 31, 2026, 17:01
Published by Dominik Martin · Software engineer and data aggregator· Methodology last reviewed: 07 May 2026· Methodology version 1.2

Data last refreshed: Aug 31, 2026, 17:01. Update cadence: weekly.

This page is not medical advice and does not replace consultation with a healthcare professional. For specific symptoms, please contact a medical professional.

About this page

Published by Renderei Martin GmbH, Berlin. No commercial interest in individual health recommendations. The app is optionally monetised via a freemium subscription.

Content is based exclusively on the linked official surveillance publications. Medical statements are curated against the guidance of RKI, ECDC and WHO.

Methodology enquiries: press@infectrisk.com

About this site and its author